Cargando…
The DAC system and associations with multiple myeloma
Despite the clear progress achieved in recent years in the treatment of MM, most patients eventually relapse and therefore novel therapeutic options are still necessary for these patients. In this regard, several drugs that target specific mechanisms of the tumor cells are currently being explored i...
Autores principales: | Ocio, Enrique M., San Miguel, Jesús F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003792/ https://www.ncbi.nlm.nih.gov/pubmed/21120582 http://dx.doi.org/10.1007/s10637-010-9589-x |
Ejemplares similares
-
The DAC system and associations with acute leukemias and myelodysplastic syndromes
por: Bug, Gesine, et al.
Publicado: (2010) -
Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019) -
Perspectives on returning to work of multiple myeloma patients: A qualitative interview study
por: Bennink, Christine, et al.
Publicado: (2021) -
Management of Pathological Thoracolumbar Vertebral Fractures in
Patients With Multiple Myeloma: Multidisciplinary
Recommendations
por: Osterhoff, Georg, et al.
Publicado: (2023) -
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
por: Maiso, Patricia, et al.
Publicado: (2021)